1. 1976 Significance of PIK3CA mutations in patients with early breast cancer treated with adjuvant chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) study. (September 2015) Authors: Papaxoinis, G.; Kotoula, V.; Alexopoulou, Z.; Charalambous, E.; Zagouri, F.; Timotheadou, E.; Gogas, H.; Pentheroudakis, G.; Koutras, A.; Christodoulou, C.; Bafaloukos, D.; Aravantinos, G.; Kalogeras, K.T.; Pectasides, D.; Fountzilas, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3: Germline sequencing of DIPNECH patients reveals a heterogeneous disease with novel SNVs in genes that are somatically mutated in other neuroendocrine malignancies. (January 2017) Authors: Hudson, A.M.; Leong, H.S.; Howell, M.; Trotter, E.; Papaxoinis, G.; Miller, C.; Nonaka, D.; Brognard, J.; Mansoor, W. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗